Q32 Bio (QTTB) Cash from Investing Activities (QoQ) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -100.02% |
| Sep 30, 2024 | 0.55% |
| Jun 30, 2024 | 10,093.81% |
| Sep 30, 2023 | -200.00% |
| Jun 30, 2023 | 120.00% |
| Mar 31, 2023 | -100.03% |
| Dec 31, 2022 | 116.62% |
| Sep 30, 2022 | -161.59% |
| Jun 30, 2022 | -124.58% |
| Mar 31, 2022 | 285.50% |
| Dec 31, 2021 | 865.10% |
| Sep 30, 2021 | 132.93% |
| Jun 30, 2021 | 83.88% |
| Mar 31, 2021 | -8,825.13% |
| Dec 31, 2020 | -102.46% |
| Sep 30, 2020 | -25.31% |
| Jun 30, 2020 | -54.77% |
| Mar 31, 2020 | 674.21% |
| Dec 31, 2019 | -52.45% |
| Sep 30, 2019 | 65.70% |
| Jun 30, 2019 | -294.75% |
| Mar 31, 2019 | 92.78% |
| Dec 31, 2018 | 122.54% |
| Sep 30, 2018 | 51.53% |
| Jun 30, 2018 | -1,506.23% |
| Mar 31, 2018 | 108.31% |
| Dec 31, 2017 | -26,575.99% |
| Sep 30, 2017 | 36.71% |
| Jun 30, 2017 | 44.22% |